Summit Therapeutics (NASDAQ:SMMT) Upgraded to Strong Sell at Leerink Partnrs
Leerink Partnrs upgraded shares of Summit Therapeutics (NASDAQ:SMMT – Free Report) to a strong sell rating in a report released on Wednesday morning,Zacks.com reports. A number of other brokerages have also recently commented on SMMT. Wall Street Zen upgraded shares of Summit Therapeutics from a “sell” rating to a “hold” rating in a research note […]
Leerink Partnrs upgraded shares of Summit Therapeutics (NASDAQ:SMMT – Free Report) to a strong sell rating in a report released on Wednesday morning,Zacks.com reports. A number of other brokerages have also recently commented on SMMT. Wall Street Zen upgraded shares of Summit Therapeutics from a “sell” rating to a “hold” rating in a research note […]
